< Back to companies

NUA Surgical was developed out of BioInnovate Ireland and is dedicated to innovating in Women's Health. The team are currently pursuing solutions to unmet clinical needs in obstetric surgery. In 2018, the founding team secured a 2 year Research and Commercialisation Grant from Enterprise Ireland to develop the SteriCISION C-Section Retractor at the National University of Ireland, Galway (NUIG). The patent pending technology is licenced to NUA Surgical Limited.In December 2018, NUA Surgical was selected to take part in the inaugural LaunchPad Lift Powered by Techstars programme. LaunchPad Lift identifies top-performing University start-ups from across the LaunchPad global network of 20 Universities, and pairs them with resources and opportunities to help their ventures succeed. In September 2019, NUA Surgical was selected as a regional finalist (Connacht & Leinster) in the InterTradeIreland Seedcorn competition.In November 2019, Barry McCann, founder and CEO of NUA Surgical was named 'Best Senior Entrepreneur' at the EIT Health Alumni Needs-Led Innovation Showcase in Lisbon, Portugal. In June 2020, NUA Surgical was one of 16 start-up companies across the UK and Ireland to receive the EIT Health Headstart award of €40,000. In December 2020, NUA Surgical was crowned the overall winner of the Intertrade Ireland Seedcorn Competition, securing €100,000 prize fund. The company is currently raising a seed investment round and is seeking suitable investors to partner with to bring their innovative technology to market.

Share
Shareable draft
Get Involved in NUA Surgical

Company Info

Founded
2019
Website
nuasurgical.com/

Categories

Innovation & Accelerator ServicesInvestment & CapitalEquity Raise

Technologies

InnovationAcceleratorsGrowth Capital
Only accessible to MedStartr community members. Join now

What do you think of NUA Surgical?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in NUA Surgical
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free